126 related articles for article (PubMed ID: 29845941)
21. Coverage of the 2011 Q fever vaccination campaign in the Netherlands, using retrospective population-based prevalence estimation of cardiovascular risk-conditions for chronic Q fever.
Vermeer-de Bondt PE; Schoffelen T; Vanrolleghem AM; Isken LD; van Deuren M; Sturkenboom MC; Timen A
PLoS One; 2015; 10(4):e0123570. PubMed ID: 25909712
[TBL] [Abstract][Full Text] [Related]
22. Shifting priorities in the aftermath of a Q fever epidemic in 2007 to 2009 in The Netherlands: from acute to chronic infection.
van der Hoek W; Schneeberger PM; Oomen T; Wegdam-Blans MC; Dijkstra F; Notermans DW; Bijlmer HA; Groeneveld K; Wijkmans CJ; Rietveld A; Kampschreur LM; van Duynhoven Y
Euro Surveill; 2012 Jan; 17(3):20059. PubMed ID: 22297101
[TBL] [Abstract][Full Text] [Related]
23. The Q fever epidemic in The Netherlands: history, onset, response and reflection.
Roest HI; Tilburg JJ; van der Hoek W; Vellema P; van Zijderveld FG; Klaassen CH; Raoult D
Epidemiol Infect; 2011 Jan; 139(1):1-12. PubMed ID: 20920383
[TBL] [Abstract][Full Text] [Related]
24. Relation between Q fever notifications and Coxiella burnetii infections during the 2009 outbreak in The Netherlands.
van der Hoek W; Hogema BM; Dijkstra F; Rietveld A; Wijkmans CJ; Schneeberger PM; Zaaijer HL
Euro Surveill; 2012 Jan; 17(3):20058. PubMed ID: 22297100
[TBL] [Abstract][Full Text] [Related]
25. Antibiotic therapy for acute Q fever in The Netherlands in 2007 and 2008 and its relation to hospitalization.
Dijkstra F; Riphagen-Dalhuisen J; Wijers N; Hak E; Van der Sande MA; Morroy G; Schneeberger PM; Schimmer B; Notermans DW; Van der Hoek W
Epidemiol Infect; 2011 Sep; 139(9):1332-41. PubMed ID: 21087542
[TBL] [Abstract][Full Text] [Related]
26. Nationwide registry-based ecological analysis of Q fever incidence and pregnancy outcome during an outbreak in the Netherlands.
de Lange MM; Hukkelhoven CW; Munster JM; Schneeberger PM; van der Hoek W
BMJ Open; 2015 Apr; 5(4):e006821. PubMed ID: 25862010
[TBL] [Abstract][Full Text] [Related]
27. Exposure to Coxiella burnetii and risk of non-Hodgkin lymphoma: a retrospective population-based analysis in the Netherlands.
van Roeden SE; van Houwelingen F; Donkers CMJ; Hogewoning SJ; de Lange MMA; van der Hoek W; Kampschreur LM; Bonten MJM; Hoepelman AIM; Bleeker-Rovers CP; Wever PC; Oosterheert JJ
Lancet Haematol; 2018 May; 5(5):e211-e219. PubMed ID: 29650493
[TBL] [Abstract][Full Text] [Related]
28. The 2007–2010 Q fever epidemic in The Netherlands: characteristics of notified acute Q fever patients and the association with dairy goat farming.
Dijkstra F; van der Hoek W; Wijers N; Schimmer B; Rietveld A; Wijkmans CJ; Vellema P; Schneeberger PM
FEMS Immunol Med Microbiol; 2012 Feb; 64(1):3-12. PubMed ID: 22066649
[TBL] [Abstract][Full Text] [Related]
29. Q fever in the Netherlands from 2007 to 2010.
Delsing CE; Kullberg BJ; Bleeker-Rovers CP
Neth J Med; 2010 Dec; 68(12):382-7. PubMed ID: 21209463
[TBL] [Abstract][Full Text] [Related]
30. Review of 20 years of human acute Q fever notifications in Victoria, 1994-2013.
Bond KA; Franklin L; Sutton B; Stevenson MA; Firestone SM
Aust Vet J; 2018 Jun; 96(6):223-230. PubMed ID: 29878326
[TBL] [Abstract][Full Text] [Related]
31. Q fever: single-point source outbreak with high attack rates and massive numbers of undetected infections across an entire region.
Hackert VH; van der Hoek W; Dukers-Muijrers N; de Bruin A; Al Dahouk S; Neubauer H; Bruggeman CA; Hoebe CJ
Clin Infect Dis; 2012 Dec; 55(12):1591-9. PubMed ID: 22918992
[TBL] [Abstract][Full Text] [Related]
32. Q fever prevention in Australia: general practitioner and stakeholder perspectives on preparedness and the potential of a One Health approach.
Rahaman MR; Hodgetts K; Milazzo A; Marshall H; Chaber AL; Crabb D; Bi P
Aust N Z J Public Health; 2022 Apr; 46(2):196-202. PubMed ID: 34941007
[TBL] [Abstract][Full Text] [Related]
33. Effects of a program to strengthen general practice care on hospitalisation rates: a comparative observational study.
Wensing M; Kolle PK; Szecsenyi J; Stock C; Laux G
Scand J Prim Health Care; 2018 Jun; 36(2):109-114. PubMed ID: 29623749
[TBL] [Abstract][Full Text] [Related]
34. [Q fever in Extremadura: an emerging infection].
Muñoz-Sanz A; Vera A; Rodríguez Vidigal FF
Enferm Infecc Microbiol Clin; 2007 Apr; 25(4):230-4. PubMed ID: 17386216
[TBL] [Abstract][Full Text] [Related]
35. Q fever cases in the Northern Territory of Australia from 1991 to 2006.
Ralph A; Markey P; Schultz R
Commun Dis Intell Q Rep; 2007 Jun; 31(2):222-7. PubMed ID: 17724999
[TBL] [Abstract][Full Text] [Related]
36. Q fever in the Netherlands: a concise overview and implications of the largest ongoing outbreak.
Delsing CE; Kullberg BJ
Neth J Med; 2008 Oct; 66(9):365-7. PubMed ID: 18931396
[TBL] [Abstract][Full Text] [Related]
37. Investigation of a slaughterhouse-related outbreak of Q fever in the French Alps.
Carrieri MP; Tissot-Dupont H; Rey D; Brousse P; Renard H; Obadia Y; Raoult D
Eur J Clin Microbiol Infect Dis; 2002 Jan; 21(1):17-21. PubMed ID: 11913496
[TBL] [Abstract][Full Text] [Related]
38. Demography of Q fever seroprevalence in sheep and goats in The Netherlands in 2008.
Van den Brom R; Moll L; van Schaik G; Vellema P
Prev Vet Med; 2013 Apr; 109(1-2):76-82. PubMed ID: 23031327
[TBL] [Abstract][Full Text] [Related]
39. Effectiveness of the Q fever vaccine: a meta-analysis.
Gefenaite G; Munster JM; van Houdt R; Hak E
Vaccine; 2011 Jan; 29(3):395-8. PubMed ID: 21094268
[TBL] [Abstract][Full Text] [Related]
40. Implementation of a Q fever vaccination program for high-risk patients in the Netherlands.
Isken LD; Kraaij-Dirkzwager M; Vermeer-de Bondt PE; Rümke HC; Wijkmans C; Opstelten W; Timen A
Vaccine; 2013 May; 31(23):2617-22. PubMed ID: 23583810
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
